Skip to main content
. 2023 Jul 28;26(3):397. doi: 10.3892/ol.2023.13983

Table IV.

Comparison of PD-L1 expression, MMR status, sex, age, BMI, smoking history, alcohol consumption, liver and peritoneal metastasis between responding and non-responding patients.

Variable n Responding group Non-responding group χ2 P-value
Sex
  Female 60 25 (36.8) 35 (27.6) 1.762 0.184
  Male 135 43 (63.2) 92 (72.4)
Age, years
  <65 120 45 (66.2) 75 (59.1) 0.949 0.330
  ≥65 75 23 (33.8) 52 (40.9)
BMI, kg/m2
  <18.5 59 23 (33.8) 36 (28.3) 0.630 0.428
  ≥18.5 136 45 (66.2) 91 (71.7)
Drinking history
  No 159 58 (85.3) 101 (79.5) 0.978 0.323
  Yes 36 10 (14.7) 26 (20.5)
Smoking history
  No 126 46 (67.6) 80 (63.0) 0.420 0.517
  Yes 69 22 (32.4) 47 (37.0)
Liver metastasis
  No 112 37 (54.4) 75 (59.1) 0.391 0.531
  Yes 83 31 (45.6) 52 (40.9)
Peritoneal metastasis
  No 152 57 (83.8) 95 (74.8) 2.096 0.148
  Yes 43 11 (16.2) 32 (25.2)
PD-L1 expression, CPS
  <5 105 19 (27.9) 86 (67.7) 28.193 <0.001
  ≥5 90 49 (72.1) 41 (32.3)
MMR status
  pMMR 178 57 (83.8) 121 (95.3) 7.299 0.007
  dMMR 17 11 (16.2) 6 (4.7)

Data are presented as n (%). BMI, body mass index; PD-L1, programmed cell death ligand-1; CPS, combined positive score; MMR, mismatch repair; dMMR, MMR deficient; pMMR, MMR proficient.